Refractory Marginal Zone Lymphoma
specificA marginal zone lymphoma that does not respond to treatment.
23
Centers
7
Active Trials
$935K
Cancer Funding
Top Centers for Refractory Marginal Zone Lymphoma(23)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 67.1 |
| 2 | NCI Comprehensive Active Research Program | 67.1 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 67.1 |
| 4 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 67.1 |
| 5 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 67.1 |
| 6 | University of Illinois Cancer CenterChicago, IL Active Research Program | 67.1 |
| 7 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 67.1 |
| 8 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 62.1 |
| 9 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 44.6 |
| 10 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 44.6 |
| 11 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 44.6 |
| 12 | NCI Comprehensive | 44.6 |
| 13 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 44.6 |
| 14 | NCI Comprehensive | 44.6 |
| 15 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 44.6 |
| 16 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 44.6 |
| 17 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 44.6 |
| 18 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 44.6 |
| 19 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 44.6 |
| 20 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 44.6 |
| 21 | Boston University Cancer CenterBoston, MA | 44.6 |
| 22 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 44.6 |
| 23 | 44.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →